The global medical electronics market is expanding as healthcare systems adopt more precise, connected, and data-driven devices. Kings Research reports that the market was valued at USD 12.73 billion in 2024 and USD 13.49 billion in 2025, and is projected to reach USD 21.19 billion by 2032, registering a compound annual growth rate (CAGR) of 6.47% over the 2025–2032 forecast period.
Medical electronics covers the design and production of electronic devices and systems used in diagnostics, monitoring, treatment, and imaging. It includes patient monitoring systems, implantable devices, diagnostic imaging equipment, and therapeutic electronics. Development relies on circuit design, miniaturization, and signal processing, all under strict regulatory compliance, and the resulting systems deliver precision, automation, and real-time data in patient care.
Market Overview
Two forces stand out in the research. First, rising demand for diagnostic imaging systems requires high-performance electronic components that deliver accuracy and efficiency. Second, the spread of Internet of Things (IoT) connected healthcare supports real-time monitoring and data integration, encouraging adoption of advanced devices across care settings.
Epidemiology is a powerful tailwind. Lifestyle-related illnesses such as diabetes, cardiovascular disease, and respiratory disorders require continuous monitoring and periodic diagnosis, which raises reliance on insulin pumps, cardiac monitors, and pulmonary function systems. Providers managing long-term conditions need accurate, real-time data, and that need is pushing them toward more advanced electronic medical systems. In August 2024, Insulet announced FDA clearance of its Omnipod 5 Automated Insulin Delivery System for adults with type 2 diabetes, making it the first such system cleared for both type 1 and type 2 diabetes.
Key Highlights from the Report
North America held a 34.09% share in 2024, valued at USD 4.34 billion. Sensors generated USD 3.81 billion in revenue among components in 2024 and are projected to reach USD 6.34 billion by 2032. Diagnostic and imaging systems are expected to reach USD 5.28 billion by 2032, and hospitals secured the largest end-use share at 33.24% in 2024. Asia Pacific is anticipated to be the fastest-growing region at a CAGR of 7.46%, reaching about USD 5.06 billion by 2032.
Market Driver: Increasing Demand for Diagnostic Imaging Systems
Computed tomography, magnetic resonance imaging, and ultrasound are central to early disease detection, and providers are investing in high-resolution technologies as a result. These systems rely on advanced electronic components for signal processing and image clarity, while continued miniaturization and innovation help hospitals and diagnostic centers improve clinical outcomes.
In February 2025, GE HealthCare unveiled the Freelium sealed MRI magnet and the Revolution Vibe CT scanner at the European Congress of Radiology. The magnet uses less than 1% of the helium needed by conventional systems, cutting operating costs and environmental impact, while the CT scanner offers ECG-less cardiac imaging and AI-driven workflow enhancements.
Market Challenge: Complex Regulatory Approvals
Navigating complex and evolving regulatory frameworks is the principal restraint. Differing standards between regions lengthen approval timelines and raise costs, delaying market entry for new devices. To manage this, manufacturers are building dedicated regulatory affairs teams, adopting global quality management systems such as ISO 13485, consulting early with regulators, and taking part in international programs like the Medical Device Single Audit Program to reduce time to market.
Market Trend: Growth in IoT-Connected Healthcare
Wearable monitors, infusion pumps, and ventilators are increasingly linked to centralized platforms, enabling seamless data sharing, remote diagnostics, and centralized monitoring. Built-in connectivity has become essential in modern healthcare networks, prompting manufacturers to develop compact, secure, and reliable communication systems tailored to clinical environments.
In May 2024, Vyvo received FDA clearance for its LifeWatch wearable, which tracks vital signs including heart rate and blood pressure and uses decentralized infrastructure technology to let users manage and monetize their health data securely.
Segmentation Insights
By component, the market spans sensors, batteries, displays, microcontrollers and microprocessors, memory chips, and other parts. Sensors led with USD 3.81 billion in 2024 because of their critical role in real-time monitoring, diagnostics, and integration with connected systems. By device, diagnostic and imaging systems held 24.88% of the market in 2024, supported by continuous demand for advanced imaging in hospitals and diagnostic centers. Other device categories include patient monitoring, active implantable devices, ventilators, and surgical robotic systems.
By end use, hospitals are projected to reach USD 6.98 billion by 2032, owing to high patient volumes, advanced infrastructure, and sustained demand for sophisticated diagnostic and monitoring equipment. Ambulatory surgical centers and home care settings are the other principal segments.
Regional Analysis
North America benefits from one of the most advanced healthcare infrastructures in the world, skilled professionals, and streamlined procurement, all of which accelerate adoption. Hospitals are at the forefront of integrating robotics and AI into surgery, diagnostics, and patient care, and these applications require electronics capable of real-time processing and precision control. In April 2025, Intuitive Surgical received FDA clearance for its SureForm 45 stapler for single-port robotic surgery, compatible with the da Vinci SP system.
Asia Pacific is growing quickly as hospitals, diagnostic centers, and specialty clinics expand in urban and semi-urban areas. Medical tourism adds momentum, because hospitals are investing in high-resolution imaging, robotic surgical equipment, and intelligent monitoring to meet international care standards. In October 2023, Medical Microinstruments entered the region through distribution agreements with Device Technologies and TRM Korea for its Symani Surgical System, subject to regulatory approvals.
Regulatory Landscape
In the United States, the FDA classifies devices into Classes I, II, and III by risk; Class II generally requires 510(k) premarket notification and Class III requires premarket approval. In the European Union, devices fall under the Medical Device Regulation and the In Vitro Diagnostic Regulation, and require CE marking, unique device identification, EUDAMED registration, and ISO 14971 risk management. China’s National Medical Products Administration requires registration, clinical evaluation, and lab testing for higher-risk devices and a local agent for foreign manufacturers. Japan’s PMDA and Ministry of Health, Labour and Welfare apply a four-class risk system with approval paths that vary by class.
Competitive Landscape
Companies are integrating advanced imaging, enhancing robotic surgical systems, and embedding AI-driven diagnostics to improve precision and safety. Profiled players include Medtronic plc, Johnson & Johnson Services, Inc., Abbott, Siemens, General Electric Company, Koninklijke Philips N.V., Stryker, Boston Scientific Corporation, Becton, Dickinson and Company, Baxter International Inc., Danaher Corporation, Intuitive Surgical, Analog Devices, Inc., TE Connectivity, and Texas Instruments Incorporated.
Recent launches show the pace of innovation. In December 2024, AUO Corporation introduced a 3D smart surgical imaging platform in Taiwan combining naked-eye 3D display with a robotic surgery system. In March 2025, Canon Medical Systems received FDA clearance for AI enhancements to its Aquilion ONE / INSIGHT Edition CT scanner and launched the Adora DRFi hybrid imaging system. Medtronic’s deep brain stimulation system gained FDA approval for Parkinson’s disease in February 2025, LifeSignals secured clearance for its UbiqVue 2A wearable biosensor in November 2024, and iRhythm obtained clearance for Zio AT enhancements in October 2024.
Outlook
As populations age, chronic disease burdens grow, and care moves toward connected and home-based models, medical electronics will remain central to healthcare delivery. Suppliers that pair advanced sensing and imaging with secure connectivity, and that navigate regulatory complexity efficiently, are well placed to capture growth through 2032.
